“After five lean years, transactions in the healthcare market rebounded spectacularly last year. But the recovery is far from uniform: investors are favoring the most advanced assets and therapeutic modalities deemed promising.”

Emmanuelle Trombe comments in L’Agefi. To read the full article (via paywall), click here.